C1657306||Reverse Genetic
C0206750||Infectious Coronaviruses
C0010076||coronaviruses
C0010076||coronaviruses
C0017296||intervention
C0017296||Rapid intervention
C0017387||genetically manipulate
C0206750||infectious CoVs
C3816499||pathogenic
C4277517||host and tissue permissibility
C0280274||antiviral therapeutic efficacy
C0010076||coronaviruses
C0035736||viral RNA
C0017428||genomes
C0028630||nucleotides
C0017387||engineering of the genome
C0017387||Deconstructing the genome
C1704681||fragments
C1705285||genetic changes
C1513776||mutated
C1704681||fragments
C1257825||genome stability
C2348563||protocol
C1657306||reverse genetic platform
C0010076||coronaviruses
C0042720||viral genome
C0010076||CoV
C0017428||genome
C0598888||subcloned
C0032136||plasmid
C1257825||stability
C0017256||amplification
C0010076||Coronavirus
C0017428||genomes
C0012906||type IIS
C0012906||IIG restriction enzyme
C1882940||recognition sites
C0598888||directional cloning
C1882940||restriction site
C1704681||fragments
C0017387||reconstruction of the full-length genome
C1155649||DNA ligation
C0486805||fragment
C0025663||method
C0314627||gene function
C0699748||pathogenesis
C0087111||therapeutics
C0010076||coronaviruses
C1515655||in vivo